Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

This phase II placebo-controlled trial showed a dramatic benefit from rituximab in preventing clinical relapses, as well as new MRI lesions, in patients with multiple sclerosis (MS).

Rituximab May Be Effective in Relapsing Multiple Sclerosis